CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income	$ 22,857	$ 9,057
Less: Income from discontinued operations	4,386	4,757
Income from continuing operations	18,471	4,300
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	14,101	16,256
Non-cash lease expense, net	(3,223)	(1,760)
Stock-based compensation expense	6,324	2,841
Deferred taxes	(17,042)	4,657
Equity in net loss (income) of unconsolidated investments	398	(22)
Other loss, net	226	716
Changes in operating assets and liabilities (net of businesses acquired):
Accounts receivable and contract assets, net	26,205	26,234
Prepaid expenses and other assets	5,431	(2,039)
Accounts payable	10,210	(2,949)
Accrued expenses	13,031	3,178
Accrued compensation and benefits	(13,291)	(13,727)
Deferred revenue	(28,352)	(23,958)
Other liabilities	2,022	1,443
Net cash provided by (used in) operating activities - continuing operations	34,511	15,170
Net cash used in operating activities - discontinued operations	34,750	(10,595)
Net cash provided by operating activities	69,261	4,575
Cash flows from investing activities:
Capital expenditures	(345)	(225)
Capitalized software	(9,600)	(8,148)
Cash paid for business acquisitions, net of cash acquired	(24,106)	0
Sale of businesses and other investments, net of cash divested, and distributions received	1,083	1,753
Purchases of equity securities, other investments and related intangible assets, net	0	(221)
Net cash used in investing activities - continuing operations	(32,968)	(6,841)
Net cash used in investing activities - discontinued operations	(11,231)	(12,148)
Net cash used in investing activities	(44,199)	(18,989)
Cash flows from financing activities:
Taxes paid related to net share settlement of equity awards	(13,275)	(4,723)
Credit facility payments	(25,000)	0
Credit facility borrowings, net of issuance costs	25,000	0
Repurchase of common stock	(49,679)	0
Intercompany to/from parent/subsidiaries	11,685	28,373
Payment of acquisition and other financing obligations	0	(1,542)
Net cash (used in) provided by financing activities - continuing operations	(51,269)	22,108
Net cash provided by (used in) financing activities - discontinued operations	(11,697)	(29,622)
Net cash used in financing activities	(62,966)	(7,514)
Effect of exchange rate changes on cash and cash equivalents	(11)	(27)
Net decrease in cash and cash equivalents	(37,915)	(21,955)
Cash, cash equivalents and restricted cash, beginning of period	190,520	537,465
Cash, cash equivalents and restricted cash, end of period	152,605	515,510
Less: Cash and cash equivalents and restricted cash included in current assets held for sale	(68,518)	(60,430)
Cash, cash equivalents and restricted cash, end of period, excluding current assets held for sale	$ 84,087	$ 455,080